AAIC 2025 Abstract
Elevated CSF levels of matrix metalloproteinase‐12 as a potential marker for microhemorrhage risk in autosomal dominant Alzheimer disease
By Nelly Joseph-Mathurin, Katherine Gong, Gengsheng Chen, Show 12 more authorsDominantly Inherited Alzheimer Network
Study in peopleBiomarkers
Abstract
Background: With the advent of disease‐modifying treatment for Alzheimer disease (AD), identifying biomarkers for predicting risk for amyloid‐related imaging abnormalities (ARIA), hemorrhagic or edema types, is of increased interest.
